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Abstract
Hypoxia is a common microenvironment in solid tumors and is correlated with tumor progression by regulating
cancer cell survival. Recent studies suggest that activation of double-stranded RNA-dependent protein kinase–like
endoplasmic reticulum–related kinase (PERK) and phosphorylation of α subunit of eIF2 (eIF2α) confer cell adapta-
tion to hypoxic stress. However, eIF2α is still phosphorylated at a lowered level in PERK knockout cells under hyp-
oxic conditions. The mechanism for eIF2α kinase(s) (EIF2AK)–increased cell survival is not clear. In this report, we
provide evidence that another EIF2AK, the amino acid starvation–dependent general control of amino acid biosyn-
thesis kinase (GCN2), is also involved in hypoxia-induced eIF2α phosphorylation. We demonstrate that both GCN2
and PERK mediate the cell adaptation to hypoxic stress. High levels of eIF2α phosphorylation lead to G1 arrest and
protect cells from hypoxia-induced apoptosis. Reduced phosphorylation of eIF2α by knocking out either PERK or
GCN2 suppresses hypoxia-induced G1 arrest and promotes apoptosis in accompany with activation of p53 signal
cascade. However, totally abolishing phosphorylation of eIF2α inhibits G1 arrest without promoting apoptosis. On
the basis of our results, we propose that the levels of eIF2α phosphorylation serve as a “switch” in regulation of G1
arrest or apoptosis under hypoxic conditions.
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Introduction
Cells respond to external stimuli by rapid changes in their translational
capacity. Stress, such as growth factor depletion, heat shock, and virus
infection, rapidly inhibits protein synthesis through phosphorylation of
the α-subunit of the eukaryotic translation initiation factor 2 (eIF2α)
[1,2]. Four kinases, the double-stranded RNA-dependent protein ki-
nase (PKR), the hemin-regulated inhibitor (HRI), the amino acid
starvation–dependent general control of amino acid biosynthesis ki-
nase (GCN2), and the PKR-like endoplasmic reticulum–related kinase
(PERK), have been identified to phosphorylate eIF2α and reduce trans-
lation initiation in response to stress [2]. Recently, PERK-mediated
phosphorylation of eIF2α has been shown to suppress protein synthesis
and cell growth on hypoxia [3–6]. In vivo studies show that hypoxia-
induced activation of PERK inhibits protein synthesis, decreases cell
growth, and promotes tumor adaptation [2–6].
Adaptation to hypoxia could also be regulated by hypoxia-inducible
factor 1 (HIF-1), which associates with tumor progression and resis-
tance to radiotherapy and chemotherapy [2,7,8]. HIF-1 is a key medi-
ator in hypoxia [9] and regulates the expressions of more than 70 genes
[10] that facilitate metabolic adaptation, cell proliferation, cell cycle
arrest, apoptosis, angiogenesis, angioinvasion, and metastasis [11,12].
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HIF-1 is a heterodimer composed of α and β subunits. The expression
of HIF-1β is constitutive, whereas the level of HIF-1α is highly reg-
ulated by oxygen levels [9]. Whereas HIF-1α undergoes rapid degra-
dation and is maintained at basal levels in normoxia, it accumulates
through protein stabilization and/or increased expression under hyp-
oxia [13,14]. HIF-1α coordinates with p53, murine double minute 2
(Mdm2), and p21WAF1 in the regulation of cell cycle arrest and apop-
tosis under hypoxic conditions. However, the regulatory mechanism
is controversial [15–17]. There are reports indicating thatHIF-1α forms
a complex with p53 and stabilizes p53 [18], which promotes cell cycle
arrest mediated by p21WAF1 and induces apoptosis [19]. Mdm2 nega-
tively regulates p53 by promoting p53 degradation [20]. Other reports
suggest that HIF-1α does not directly associate with p53, but with
Mdm2 [17,21], which upregulates HIF-1α levels [17,22,23]. The
mechanism for hypoxia-mediated cell cycle arrest and apoptosis re-
mains unclear [24–26]. In this report, we provide pieces of evidence
that translation initiation plays a critical role in regulation of hypoxia-
induced signaling circuit. Under hypoxic conditions, PERK and GCN2
are activated and coordinately phosphorylate eIF2α. Depending on
the levels of eIF2α phosphorylation, the expression and activity of
HIF-1α, p53, Mdm2, and p21WAF1 are altered under hypoxic condi-
tions. Our findings not only significantly advance the understanding
of the mechanism for hypoxia/eIF2α phosphorylation–mediated G1
arrest and apoptosis signaling circuit but also lead to the discovery of
a potential target for antitumor therapies.
Materials and Methods
Cell Culture and Hypoxic Treatments
Mouse embryonic fibroblast (MEF)wild type (MEFWT),MEFPERK
knockout (MEFPERK−/−), MEF GCN2 knockout (MEFGCN2−/−), and
MEF S51A mutant (MEFA/A), in which the wild type eIF2α was re-
placed with a nonphosphorylatable S51A mutated eIF2α, were kindly
provided by Dr. RJ Kaufman (University of Michigan Medical School,
Ann Arbor, MI). The cells were cultured in Dulbecco’s modified Eagle
medium (DMEM; Cellgro, Manassas, VA) supplemented with 1% pen-
icillin and streptomycin and 10% fetal bovine serum (Cellgro) at 37°C
with 5% CO2. GasPak EZ Anaerobe Pouch System (BD Biosciences,
VWR, S. Plainfield, NJ) was used to reduce the oxygen levels to less than
1% (mean, 0.7%) in 90 minutes.
Western Blot Analysis
The cells were washedwith cold phosphate-buffered saline (PBS) twice
and lysed in buffer with 50 mM Tris-HCl, 150 mM NaCl, 0.05%
EDTA, 0.5% IGEPAL CA-630, and a cocktail of protease inhibitors
(Roche, Indianapolis, IN). An equal amount of total proteins was sepa-
rated by SDS-PAGE. Protein was electroblotted onto Immobilon-P
membrane (Millipore, Temecula, CA), which was then blocked with
5% milk in PBST (PBS with 0.1% Tween-20). The interested pro-
teins were probed with the corresponding antibodies and visualized by
LumiGLO reagent and peroxide (Cell Signaling, Danvers, MA). Anti-
eIF2α, anti–phosphorylated eIF2α (Ser 51), and anti–β-actin were pur-
chased from Sigma (St. Louis, MO). Anti-Mdm2 (N-20), anti-p53
(Bp53), anti–HIF-1α, and secondary horseradish peroxidase–linked anti-
bodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Cell Viability Assay
The cells (1 × 105) were seeded in 12-well plates and were then
exposed to normoxia or hypoxia. The viability was measured at dif-
ferent time points by the CellTiter-Glo Luminescent Cell Viability
Assay kit (Promega, Madison, WI) according to the manufacturer’s
protocol. After removing the medium, 75 μl of CellTiter-Glo reagent
was diluted once with water and added into each well. The cells were
incubated with reagent at room temperature on a shaker for 5 min-
utes and then incubation was continued for 10 minutes. Lumines-
cence of each sample (100 μl) was measured by a Lumat LB9507
luminometer (Berthold Technologies, Oak Ridge, TN).
Cell Cycle Analysis
The cells (2 × 106) were seeded in 100-mm tissue culture plates
and exposed to normoxia or hypoxia. The cells were harvested and
washed twice with cold PBS. The cells were suspended in 200 μl
of PBS and fixed in 4 ml of cold 70% ethanol at −20°C overnight.
The cells were centrifuged at 4°C for 10 minutes. The cell pellets
were stained by a propidium iodide mixture (100 μg/ml RNase and
50 μg/ml propidium iodide) at 37°C for 30 minutes. The amount of
apoptotic cells in a total of 1 × 104 cells was determined by a flow
cytometer (Becton Dickinson, San Jose, CA) and analyzed by ModFit
LT (Verity Software House, Topsham, ME).
Apoptosis Assay
The cells (2 × 105) were seeded in 12-well plates and exposed to
normoxia or hypoxia for 2 days. The cells were analyzed by a Cell
Death Detection ELISA kit (Roche Diagnostics), which measures
cleaved histone and DNA complex. The assay was performed accord-
ing to the manufacturer’s manual. The absorbance at 405/590 nm
was measured by a SPECTRA Max M2 multichannel fluorescence
plate reader (Molecular Devices, Sunnyvale, CA).
Luciferase Assay
Cells were seeded in 24-well plates and cotransfected with an in-
ducible luciferase expression vector and a Renilla luciferase expression
vector (Panomics, Fremont, CA). At 24 hours after transfection, the
cells were exposed to normoxia or hypoxia. The luciferase activities
were measured by a Dual-Luciferase Reporter Assay kit (Promega)
according to the manufacturer’s manual. Luciferase and Renilla lucif-
erase activities were measured by a Lumat LB 9507 luminometer
(Berthold Technologies). The Renilla luciferase activity was used to
normalize the transfection efficiency.
Glucose Uptake Assay
The cells were washed with serum-free DMEM twice and then cul-
tured under hypoxia with serum-free medium for 12 hours. The cells
were washed with Kreb’s Ringer phosphate (CRP) buffer (136 mM
NaCl, 4.7 mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 8.1 mM
Na2HPO4, 1.9 mM NaH2PO4) twice and then incubated with 450 μl
of KRP buffer for 30 minutes. Fifty microliters of KRP supplemented
with 1 μCi/ml [3H] 2-deoxy-D-glucose and 1 mM glucose was added
to each sample and incubated for 30 minutes at 4°C. The buffer was
removed, and the cells were washed twice with cold PBS. Cells were lysed
with 350 μl of 0.2 MNaOH. Radioactivity was determined by LS 6500
multipurpose scintillation counter (Beckman Coulter, Fullerton, CA).
Clonogenic Assay
The cells (5 × 103) were seeded in six-well plates and cultured in 95%
air and 5% CO2 at 37°C for 6 days. The cells were then washed with
PBS twice and fixed by coldmethanol for 10minutes at −20°C.The fixed
cells were stained by 1% crystal violet in 25% methanol for 10 minutes
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at room temperature. The cells were finally rinsed with distilled water,
and the colonies with a size more than 0.5 mm were counted.
Statistical Analysis
Student’s t test was used to analyze the significance of data. P < .05
was considered significant.
Results
Hypoxia-Induced Cell Death Is Protected by PERK and GCN2
in an eIF2α Phosphorylation-Independent Manner
PERK has been suggested to mediate the hypoxia-induced phos-
phorylation of eIF2α and increase tolerance of tumor cells to hypoxic
stress [3,4,26]. However, whereas the thapsigargin-induced eIF2α
phosphorylation is totally inhibited in MEFPERK−/− cells, the hypoxia-
induced phosphorylation is only partially inhibited in the same cells
[26]. The results suggested that other eIF2α kinase (EIF2AK) besides
PERK might also be involved in the hypoxia-induced eIF2α phos-
phorylation. Our recent study demonstrated that GCN2 coordinates
with PERK in regulation of UVB-induced phosphorylation of eIF2α
[27]. To determine whether GCN2 is also involved in hypoxia-induced
phosphorylation of eIF2α, we analyzed time-dependent phosphoryla-
tion of eIF2α in MEFWT, MEFPERK−/−, MEFGCN2−/−, and MEFA/A
cells after modest hypoxia treatment. As expected, whereas eIF2α was
not phosphorylated in MEFA/A cells, an increased phosphorylation of
eIF2α was detected at 2 hours after treatment in the other cell lines.
Figure 1. Both PERK and GCN2 mediate hypoxia-induced eIF2α phosphorylation and cell death. MEFWT, MEFPERK−/−, MEFGCN2−/−, and
MEFA/A cells were used in the experiments as indicated. (A) The cells were exposed to hypoxia for the indicated time points before
immunoblot analysis with phosphorylated eIF2α (Ser 51) and total eIF2α antibodies. (B) The cells were exposed to normoxia or hypoxia
for the indicated time points and then viability assays were performed. The bars represent the means of three independent experiments.
(C) The cells were exposed to hypoxia for 12 hours with serum-free DMEM and were then fed with glucose supplemented with [3H] 2-
deoxy-D-glucose. Total protein was collected, and the radioactivity was measured by liquid scintillation counter. The bars represent the
means of three independent experiments. *P < .05 mutant versus wild type. (D) The cells were exposed to normoxia or hypoxia for
indicated time points and photographed using microscopy equipped with a Nikon digital camera (Nikon, West Chester, OH).
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Compared with MEFWT cells, the hypoxia-induced phosphorylation of
eIF2α was delayed and reduced in MEFPERK−/− cells (Figure 1A), which
agreed with previous reports [26,28]. Moreover, our data also showed
that the phosphorylation of eIF2α was similarly delayed and reduced in
MEFGCN2−/− cells (Figure 1A). These results demonstrate that both
PERK and GCN2 are involved in the hypoxia-induced phosphoryla-
tion of eIF2α.
It has been found that hypoxia-induced PERK activation protects
cells from death by increasing eIF2α phosphorylation [3]. To determine
whether GCN2 can also protect cells from hypoxia-induced death, we
analyzed viabilities ofMEFWT,MEFPERK−/−,MEFGCN2−/−, andMEFA/A
cells under normoxic or hypoxic conditions. Our data showed that, un-
der normoxic conditions, the growth rates of MEFWT, MEFPERK−/−,
MEFGCN2−/−, and MEFA/A were within 10% differences (Figure 1B,
Normoxia), but under hypoxic conditions, viabilities of MEFGCN2−/−
and MEFPERK−/− cells decreased more rapidly than MEFWT and
MEFA/A cells (Figure 1B, Hypoxia). After correcting the survival rates
in hypoxia with the growth rates in normoxia, our data demonstrated
that the survival rates for MEFGCN2−/− and MEFPERK−/− cells were de-
creased in 48 hours to 2.4 ± 0.1% and 5.1 ± 0.3%, respectively (Fig-
ure 1B, Hypoxia/Normoxia). Surprisingly, the survival rate of MEFA/A
cells was 47.3 ± 3.2%, which was similar to the 44.9 ± 2.1% survival rate
of MEFWT cells (Figure 1B, Hypoxia/Normoxia).
To further confirm the above results, we analyzed cell viabilities
using metabolic and morphologic analyses. Glucose uptake assay was
used to measure the metabolic activities of the cells in hypoxia. Our
data showed that whereas the metabolic activities of MEFWT and
MEFA/A cells were maintained at 75.4 ± 0.3% and 83.5 ± 0.4%, re-
spectively, the activities in MEFGCN2−/− and MEFPERK−/− cells were de-
creased to 36.0 ± 0.2% and 42.3 ± 0.2%, respectively (Figure 1C). In
addition, the morphologic analysis also showed that the MEFGCN2−/−
and MEFPERK−/− cells were more sensitive to hypoxia than MEFWTand
MEFA/A cells (Figure 1D). These results confirmed that the hypoxia-
induced cell death depended on but not linearly related to the levels
of eIF2α phosphorylation.
To determine whether PERK or GCN2 influences cell survival in
hypoxia independently of eIF2α, we tried to knockout PERK or
GCN2 in theMEFA/A cells using a siRNAmethod. Our results showed
that when PERK or GCN2 siRNA reduced the viability of MEFWT
cells under hypoxia, they did not affect the viability of MEFA/A cells
(Figure W1A). The preliminary result suggests that PERK- and
GCN2-mediated hypoxia-induced cell death is eIF2α-dependent.
However, our data are not conclusive because the transfection efficiency
is less than 20% based on the control FITC-labeled scramble siRNA
(Figure W1B).
Hypoxia-Induced Cell Cycle Arrest Is Dependent on PERK
and GCN2 by Regulating HIF-1α and p21WAF1
Both PERK and GCN2 contribute to cell cycle arrest on endoplasmic
reticulum stress [29]. To determine whether both PERK andGCN2 play
a role in the regulation of cell cycle arrest in hypoxia, we performed cell
cycle analysis in MEFWT,MEFGCN2−/−, MEFPERK−/−, andMEFA/A cells.
Our data showed that hypoxia inducedG1 arrest inMEF
WT cells but not
in MEFPERK−/−, MEFGCN2−/−, or MEFA/A cells (Figure 2A). These data
demonstrate that the activation of PERK/GCN2 and the phosphoryla-
tion of eIF2α are essential for hypoxia-induced cell cycle arrest.
To assess the molecular mechanism for PERK/GCN2–mediated
eIF2α phosphorylation in regulation of cell cycle arrest, we analyzed
the expressions of HIF-1α and p21WAF1, the key cell cycle regulators
in hypoxia [25,30]. Our data showed that HIF-1α expression was in-
duced in MEFWT (Figure 2B). The hypoxia-inducibility of HIF-1α ex-
pression was eliminated or reduced in MEFPERK−/− and MEFGCN2−/−
cells (Figure 2B). HIF-1α was not detected in MEFA/A cells in either
normoxia or hypoxia (Figure 2B). In contrast to HIF-1α, the maximal
inducibility of p21WAF1 in hypoxia was achieved in MEFWT cells (Fig-
ure 2B). The inducibility, but not the expression levels of p21WAF1,
was correlated to the hypoxia-induced cell cycle arrest. These results
suggest that the hypoxia-induced cell cycle arrest is mediated by the
inductions of HIF-1α and p21WAF1, which is regulated by PERK/
GCN2–mediated eIF2α phosphorylation.
PERK and GCN2 Protect Cells from
Hypoxia-Induced Apoptosis
To determine whether GCN2, like PERK, protects cells from hypoxia-
induced apoptosis, we assessed the roles of PERK/GCN2–mediated
eIF2α phosphorylation in regulation of apoptosis under hypoxia.
MEFWT, MEFPERK−/−, MEFGCN2−/−, and MEFA/A cells were exposed
Figure 1. (continued).
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Figure 2. Hypoxia induces G1 arrest in MEF
WT but not in MEFPERK−/−, MEFGCN2−/−, and MEFA/A cells. (A) The cells were treated with
hypoxia for 12 hours before the cell cycle analysis using flow cytometry. The data were analyzed by ModFit software. The bars represent
the means of three independent experiments. *P < .05 hypoxia versus normoxia. (B) The cells were treated with hypoxia for the time
points as indicated, and the protein levels of HIF-1α and p21WAF1 were analyzed by Western blot.
Figure 3. Both PERK and GCN2 regulate p53 signaling cascade and apoptosis in hypoxia. MEFWT, MEFPERK−/−, MEFGCN2−/−, and MEFA/A
cells were used in the experiments. (A) The cells were exposed to normoxia or hypoxia for 36 hours before apoptotic assays by detecting
cleaved histone/DNA complex. The bars represent the means of three independent experiments. *P < .05 mutant versus wild type under
normoxia or hypoxia. (B) The cells were treated with hypoxia for the time points as indicated and the protein level of Mdm2 was analyzed
by Western blot. (C and D) The cells were cotransfected with p53 luciferase reporter plasmid or Bax luciferase reporter plasmid. Renilla
luciferase reporter plasmid was used to normalize the transfection efficiency. Twenty-four hours after transfection, the cells were exposed
to normoxia or hypoxia for 24 hours, and the activities of p53 and Bax were analyzed by luciferase assay. The bars represent the means of
three independent experiments. *P < .05 mutant versus wild type.
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to hypoxic stress, and then apoptotic cell death was analyzed by exam-
ining the cleavage of histone-DNA complex. Our data showed that
higher levels of nucleosome contents were displayed in MEFPERK−/−
and MEFGCN2−/− cells than the levels in MEFWT and MEFA/A cells
(Figure 3A). The result indicates that both PERK and GCN2 are in-
volved in the regulation of apoptotic cell death in hypoxia.
Because p53 plays a central role in regulation of apoptosis during
hypoxia [31–34], we determined whether PERK and GCN2 would
protect cells from hypoxia-induced apoptosis via regulating p53 sig-
naling pathway. Our data demonstrated that p53 was increased in the
four cell lines on hypoxic stress (Figure 3B). However, the maximal
inducibility of p53 was achieved in MEFPERK−/− and MEFGCN2−/−
cells (Figure 3B). At the same time, the expression of a p53 negative
regulator, Mdm2, was decreased in all cell lines independent of
eIF2α phosphorylation levels (Figure 3B). These results suggest that
activation of PERK and GCN2 inhibits hypoxia-induced activation of
p53 signaling pathway independent of Mdm2. To confirm the results
that the maximal inducibility of p53 was achieved in MEFPERK−/− and
MEFGCN2−/− cells, we used p53 transcriptional activity–regulated lucif-
erase expression system to determine p53 DNA binding ability. Our
data showed that p53 transcriptional activity was up to 4.0 ± 0.5- and
4.4 ± 0.8-folds in MEFPERK−/− and MEFGCN2−/− cells, whereas the ac-
tivity was only up to 1.4 ± 0.1- and 1.7 ± 0.1-folds in MEFWT and
MEFA/A cells, respectively, in hypoxia (Figure 3C ). The promoter ac-
tivity of a p53 downstream gene, Bax, was also upregulated more in
MEFGCN2−/− andMEFPERK−/− cells than inMEFWTandMEFA/Acells (Fig-
ure 3D). These results suggest that the lowered viability in MEFPERK−/−
and MEFGCN2−/− cells was due to the upregulated apoptosis, which
was mediated by p53 signaling pathways.
PERK, GCN2, and Phosphorylated eIF2α Promote Recovery
of Cells from Hypoxia
The ability to recover from stress is also an important property to
measure the regulation of survival and growth of cells after exposure to
a stress. We determined whether PERK/GCN2–mediated eIF2α
phosphorylation affects the ability of cells to recover from hypoxia.
Clonogenic assay was used to measure survival and recovery of cells
from hypoxic stress. The MEFWT, MEFPERK−/−, MEFGCN2−/−, and
MEFA/A cells were exposed to hypoxia for 24 hours and then cultured
under normal conditions for 6 days. Our data showed that, compared
with MEFWT cells, the survival rates after hypoxia were reduced 50.5 ±
8.4% and 50.0 ± 2.9% for MEFPERK−/− and MEFGCN2−/− cells, re-
spectively (Figure 4A). The survival rate of MEFA/A cells was reduced
only by 5.9 ± 5.9% (Figure 4A). Noticeably, the sizes of MEFA/A col-
onies were much smaller than the other three cell lines (Figure 4B),
indicating that eIF2α phosphorylation was required for cell growth
during recovery but not required for cell survival on hypoxia. These
data demonstrate that partial reduction of eIF2α phosphorylation
(PERK or GCN2 knockout) decreases cell recovery by lowering sur-
vival rate, whereas total elimination of eIF2α phosphorylation (eIF2α
S51A mutation) decreases cell recovery by lowering cell growth rate
Figure 4. Both PERK and GCN2 mediate recovery of cells from hyp-
oxic stress. MEFWT, MEFPERK−/−, MEFGCN2−/−, and MEFA/A cells
were exposed to hypoxia for 24 hours. Cells were collected and
stained by Trypan blue. Nonapoptotic cells were counted. Five thou-
sand cells were replated and cultured under normoxia for 6 days.
Cells were then fixed by methanol for 10 minutes at −20°C and
stained by 1% crystal violet (25% methanol) for 10 minutes,
washed by distilled water, and dried. (A) The colonies with a size
greater than 0.5 mm were counted. The degree of colony formation
was expressed as percentage of MEFWT cells. The bars represent
the means of three independent experiments. *P < .05 mutant ver-
sus wild type. (B) The plates were photographed using microscopy
equipped with a Nikon digital camera.
Figure 5. The model for the roles of eIF2α phosphorylation in cell fate determination.
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during reoxygenation after hypoxic stress. These results suggest that
the hypoxia-induced activation of PERK/GCN2 and eIF2α phos-
phorylation coordinatively regulate cell growth and apoptosis after
hypoxic stress.
Discussion
A hypoxic microenvironment in solid tumors often correlates with
tumor progression and therapy resistance [35]. HIF-1α is a key reg-
ulator in response to hypoxia and has been shown to regulate angio-
genesis, metabolic adaptation, proliferation, apoptosis, and invasion
[9–12,36–39]. Hypoxia increases cancer cell–induced lymphatic
endothelial cell invasion and migration [40], whereas it decreases
macromolecular synthesis and slows down cell proliferation [2,41].
Prolonged hypoxia also induces an energy-depleting response that
activates mammalian target of rapamycin–signaling network [42].
Recent studies show that hypoxia activates PERK, which phosphor-
ylates eIF2α, reduces protein synthesis, and contributes to hypoxic
adaptation [3–6,26,28]. However, in hypoxic cells lacking PERK,
the phosphorylation of eIF2α on Ser 51 is still upregulated [26],
which indicates that there could be other EIF2AKs activated in hyp-
oxia. In this study, we demonstrate that similar to MEFPERK−/− cells,
the phosphorylation of eIF2α in MEFGCN2−/− cells was also delayed in
hypoxia (Figure 1A), suggesting that GCN2 is also involved in the
phosphorylation of eIF2α in response to hypoxia. Besides PERK
and GCN2, HRI and PKR can also phosphorylate eIF2α. Although
PKR has been shown not to induce eIF2α phosphorylation under
hypoxia [26], we cannot rule out that HRI is also involved in hypoxia-
induced eIF2α phosphorylation.
Our results suggest that reduction of eIF2α phosphorylation by
PERK or GCN2 knockout sensitized the cells to hypoxia-induced
cell death (Figures 1 and 4), but elimination of eIF2α phosphory-
lation by eIF2α S51A knock-in had no effects on the cell survival
under the same conditions (Figures 1 and 4). These results disagree
with the previous in vitro study indicating that abolishing eIF2α
phosphorylation reduces cell survival in hypoxia [3]. However, our
results agree with the in vivo data in the same report, which shows
that the tumor volume from MEFA/A cells is much larger than
the tumors from MEFPERK−/− cells but is smaller than the tumors
from MEFWT cells. Because tumor hypoxia is transient in vivo and
reoxygenation also affects tumor survival and growth, we further con-
firm our in vitro data by investigating the survival and recovery on
hypoxia-reoxygenation in the four cell lines. Our data from the via-
bility and colonogenic assays indicate that partial reduction of eIF2α
phosphorylation by knocking out either PERK- or GCN2-promoted
cell death but did not affect cell growth on hypoxia-reoxygenation
(Figure 4). In contrast, totally abolished eIF2α phosphorylation did
not influence cell survival but promoted cell growth on hypoxia-
reoxygenation (Figure 4). These results suggest that PERK/GCN2
knockout affects cell growth and death on hypoxia-reoxygenation
through differential mechanism as eIF2α S51A mutation does. The
controversial observation with the previous in vitro data [3] may be
due to the experimental conditions. We used moderate hypoxia
(∼1% oxygen), which is close to the physiological condition in solid
tumor [43,44]. However, the previous study was performed under ex-
treme hypoxia (<0.02% oxygen) [3].
To further analyze the mechanism for EIF2AKs and eIF2α
phosphorylation–regulated tumor progression in hypoxia, we analyzed
their roles in regulating the expressions of several key hypoxia-induced
factors, such as HIF-1α and p53 [25,31–34,39,45]. The correlations
among the gene expression patterns, cell cycle arrest, and apoptosis
were also studied. Our data showed that the hypoxia-induced eIF2α
phosphorylation is critical in the regulation of the inducibility and
expression of HIF-1α and p21WAF1 (Figure 2). However, only the
inducibilities, but not the levels, of HIF-1α and p21WAF1 expression
were correlated to hypoxia-induced cell cycle arrest (Figure 2). Whereas
PERK and GCN2 are required for hypoxia-induced HIF-1α/p21WAF1
expression, they suppress hypoxia-induced activation of p53 (Figure 3).
Elimination of PERK or GCN2 activity also sensitizes the cells to
hypoxia-induced apoptosis (Figure 3). Interestingly, totally abolishing
eIF2α phosphorylation has no effects on p53 activation and apoptosis
(Figure 3), but affects HIF-1α/p21WAF1 inducibility and G1 arrest
after hypoxic stress (Figure 2). The mechanism could be due to the
extremely low expression of HIF-1α in both normoxia and hypoxia
(Figure 2B), which plays a critical role in regulation of hypoxia-induced
cell cycle arrest [46]. On the basis of these results, we propose that
PERK/GCN2–mediated eIF2α phosphorylation serves as a “switch”
that determines the fate of cells after hypoxic stress (Figure 5). A lower
level of eIF2α phosphorylation “turns on” a death signal by inhibiting
G1 arrest and promoting apoptosis through activating p53 signal cas-
cade. In contrast, higher levels of eIF2α phosphorylation “switch” the
death signal to an adaptive signal by promoting G1 arrest and reducing
apoptosis through activating the HIF-1α/p21WAF1 signaling pathway.
Our proposed model has the potential to be used to develop new ther-
apeutics for cancer treatment by targeting PERK/GCN2–meidated
eIF2α phosphorylation.
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Figure W1. (A) siRNAs were transfected into MEFWT and MEFA/A cells to knock down PERK or GCN2. The transfected cells were ex-
posed to hypoxia for 24 hours and viability was measured. (B) GFP vector was transfected into MEFWT and MEFA/A cells to show the
transfection efficiency.
